NASDAQ:ONTX   Onconova Therapeutics, Inc
A retest and continuation of the 0.382 fibs would be the most aggressive and likely realistic entry


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.